PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study

PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study

Dazhen Wang,1,* Zhengfeng Zhang,2,* Liu Yang,1 Lu Zhao,1 Ze Liu,1 ChangJie Lou1 1Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150081, People’s Republic of China; 2Department of Hematopathology, The Second Clinical Medical College, J...

Full description

Bibliographic Details
Main Authors: Wang D, Zhang Z, Yang L, Zhao L, Liu Z, Lou C
Format: Article
Language:English
Published: Dove Medical Press 2024-06-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
hepatic artery infusion chemotherapy
programmed cell death protein-1
tyrosine kinase inhibitors
systemic inflammatory response index
albumin-bilirubin
Online Access:https://www.dovepress.com/pd-1-inhibitors-combined-with-tyrosine-kinase-inhibitors-with-or-witho-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/pd-1-inhibitors-combined-with-tyrosine-kinase-inhibitors-with-or-witho-peer-reviewed-fulltext-article-JHC

Similar Items